Nymox Pharmaceutical Stock Price (NASDAQ:NYMX)

Add to My Stocks
$3.21 $0.02 (0.62%) NYMX stock closing price Mar 24, 2017 (Closing)
Prev Close* : $3.23
Market Cap:
$148.26M
Day Low: $3.18
52 Week Low: $1.62
Open: $3.22
Volume: 33457
Day High: $3.27
52 Week High: $5.79
Dividend:
N/A

Latest Stock Market News

Latest Articles

Nymox Pharmaceutical News - From Partners

NYMX Stockcharts

View NYMX PE ratio, PS ratio stocks charts and compare with peers.
NYMX Chart
Note: Compare Nymox Pharmaceutical stock price history with the index and industry peers.

Nymox Pharmaceutical Valuation

PS ratio (
price to sales ratio
)
470.37

Nymox Pharmaceutical Financial Ratios

Asset Turnover
0.2
Receivables Turnover
1.58

NYMX Industry Peers

Company Price Change (%)
Cellular Biomedicine (CBMG)11.350.2 (1.79%)
Uniquire (QURE)5.810.13 (2.29%)
Albireo Pharma (ALBO)22.50.21 (0.92%)
Adocia (ADOCY)22.670 (0%)
Baxalta (BXLT)46.020.18 (0.39%)
Regeneron Pharma (REGN)3737.98 (2.19%)
Alexion Pharma (ALXN)119.261 (0.83%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Enzo Biochem (ENZ)8.430.52 (6.57%)
Peregrine Pharma (PPHM)0.7060.03 (4.44%)
Ophthotech (OPHT)3.530.15 (4.44%)
Kindred Biosciences (KIN)7.20.3 (4.35%)
Fortress Biotech (FBIO)3.60.14 (4.05%)
Immunomedics (IMMU)6.880.25 (3.77%)
Compugen (CGEN)4.350.15 (3.57%)
Top gainers from Medical-Biomed-Genetics industry
* As of Mar 25, 2017
CompanyPriceChange (%)
BioDelivery Sciences (BDSI)1.750.18 (9.35%)
Vital Therapies (VTL)3.850.15 (3.75%)
MannKind (MNKD)1.890.06 (3.08%)
PDL BioPharma (PDLI)1.980.05 (2.46%)
Sangamo BioSciences (SGMO)4.10.1 (2.38%)
Sorrento Therapeutics (SRNE)4.10.1 (2.38%)
Ultragenyx Pharma (RARE)70.321.67 (2.32%)
Top losers from Medical-Biomed-Genetics industry
* As of Mar 25, 2017

Nymox Pharmaceutical Financial Statements

income statement20152014201320122011
Net Sales Or Revenues2.76M2.94M3.35M3.07M3.11M
Net Income-17.88M-4.59M-4.9M-7.62M-9.65M
Total Operating Expense20.25M7.49M7.74M10.41M12.44M
view Nymox Pharmaceutical Corporation income statement
balance sheet20152014201320122011
Total Assets0.71M1.42M0.96M1.75M6.37M
Total Liabilities3.46M5.6M7.02M9.19M11.57M
Shareholders Equity-2.75M-4.18M-6.05M-7.44M-5.19M
view Nymox Pharmaceutical Corporation balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities-1.74M-2.3M-2.12M-2.64M-4.5M
Net Cash From (Used By) Operating Activities-3.75M-5.51M-6.71M-8.3M-10.13M
Increase (Decrease) In Prop Plant And Equipment---0.01M--0.02M
view Nymox Pharmaceutical Corporation cashflow statement

Nymox Pharmaceutical Stock Message Board

Nymox Pharmaceutical stock price ended the last trading day at 3.21. The total market value as denoted by 149.19M for Nymox Pharmaceutical, is the market value of the company's outstanding shares. Nymox Pharmaceutical valuation can be guaged using various valuation metrics like the price to earnings ratio.

The terms stocks and shares mean the same thing. For Ex: Nymox Pharmaceutical stock price and Nymox Pharmaceutical share price mean the same thing. The volume of shares traded stood at 33457 on the last trading day, as is evident from Nymox Pharmaceutical stock chart, and NYMX stock quote data. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Nymox Pharmaceutical stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.